Cardurion Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Cardurion Pharmaceuticals's estimated annual revenue is currently $8.1M per year.
- Cardurion Pharmaceuticals's estimated revenue per employee is $118,529
- Cardurion Pharmaceuticals's total funding is $622M.
Employee Data
- Cardurion Pharmaceuticals has 68 Employees.
- Cardurion Pharmaceuticals grew their employee count by 42% last year.
Cardurion Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO and President | Reveal Email/Phone |
2 | Office Manager and Executive Assistant to CEO | Reveal Email/Phone |
3 | President and CEO | Reveal Email/Phone |
4 | Chief Medical and Scientific Officer | Reveal Email/Phone |
5 | Founder and Chief Strategy Officer | Reveal Email/Phone |
6 | Chief Business Officer | Reveal Email/Phone |
7 | Chief People Officer | Reveal Email/Phone |
8 | Founder and Chairman | Reveal Email/Phone |
9 | VP/Head, Biometrics | Reveal Email/Phone |
10 | SVP, Technical Operations | Reveal Email/Phone |
Cardurion Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 1 | -50% | N/A | N/A |
#3 | $5.1M | 33 | 22% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 2 | -60% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | N/A | 11 | 10% | N/A | N/A |
#10 | $5.4M | 29 | 0% | N/A | N/A |
What Is Cardurion Pharmaceuticals?
Cardurion is a clinical-stage cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. Cardurion's product pipeline includes our lead clinical asset, CRD-733, a PDE-9 inhibitor with the potential to improve cardiac function in heart failure patients. Cardurion has an exclusive licensing agreement with Astellas for the development and commercialization of CRD-733. Additionally, Cardurion has a strong cardiovascular development partnership with Takeda which is fueling drug discovery and preclinical development work being conducted in our internal research laboratories.
keywords:N/A
$622M
Total Funding
68
Number of Employees
$8.1M
Revenue (est)
42%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cardurion Pharmaceuticals News
Cardurion Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation...
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13.5M | 68 | 6% | N/A |
#2 | $4.7M | 68 | 21% | $22.5M |
#3 | $8.6M | 68 | -15% | $40M |
#4 | $16.5M | 68 | 5% | N/A |
#5 | $10.4M | 68 | 5% | N/A |